FDA classifies recall of Medtronic embolization devices as 'most serious'
The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as "most serious", ...
Becker's Hospital Review46 分钟
Medtronic recalls embolization devices; 4 deaths reported
Medtronic has recalled certain Pipeline Vantage Embolization Devices with Shield Technology due to an increased risk of ...
Medtronic recalls embolization devices tied to 17 injuries, 4 deaths
Medtronic will remove one model of Pipeline Vantage devices from where they’re used and sold and will update the instructions ...
American Hospital Association2 小时
FDA issues recall on Medtronic embolization devices
The Food and Drug Administration has identified a Class I recall of Medtronic Neurovascular 027 Compatible Pipeline Vantage ...
Taiwan News9 小时
Terumo Neuro Celebrates 15 Years of the WEB™ Device: A Game-Changing Innovation in ...
Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, proudly marks ...
FDA issues Medtronic embolization device recall and correction notice
In a notice posted to the agency’s website, the FDA noted that on January 30, 2025, Medtronic (MDT) Neurovascular sent all affected customers ...
Endovascular Today1 天
Medtronic Recalls Pipeline Vantage 027, Updates IFU for Pipeline Vantage 021
The FDA announced that Medtronic initiated a device recall and correction for embolization devices. The FDA has identified ...
Targeted Oncology8 天
Current Treatment Practices in Embolization-Eligible HCC
Panelists discuss how systemic therapy plays a crucial role in embolization-eligible hepatocellular carcinoma (HCC), ...
Medscape8 天
Uterine Artery Embolization for Fibroids: Considerations in Patient Selection and Clinical ...
Since we began performing uterine artery embolization for fibroids, we have received numerous direct inquiries from women, their husbands, and their primary care physicians. We were initially ...
Medtronic slips after FDA notice on product recall (update)
Shares of Medtronic (NYSE:MDT) reached a session low on Tuesday after the U.S. Food and Drug Administration (FDA) announced a ...
Taiwan News2 天
NEXTBIOMEDICAL, Fast Resorbable Microsphere 'Nexsphere-F' : Clinical Study Results on 155 ...
SEOUL, South Korea, March 17, 2025 /PRNewswire/ -- NEXTBIOMEDICAL CO., LDT, announced that clinical study results of Nexsphere-F™, a resorbable embolic agent for treating joint pain, have been ...